Sort   by:  
 Page size 
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052784 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052798 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
UnknownIntegrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH.
Not available
S-EPMC12147855 | biostudies-literature
Sort   by:  
 Page size